W"H-Y" Antigen/HLA Complexes in Chronic GVHD

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2023 Sep 14

PMID 37707875

Authors

Noa G Holtzman

Steven Z Pavletic

Affiliations

Soon will be listed here.

References

McManigle W, Youssef A, Sarantopoulos S . B cells in chronic graft-versus-host disease. Hum Immunol. 2019; 80(6):393-399. PMC: 8049519. DOI: 10.1016/j.humimm.2019.03.003. View

Zorn E, Miklos D, Floyd B, Mattes-Ritz A, Guo L, Soiffer R . Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. J Exp Med. 2004; 199(8):1133-42. PMC: 1361263. DOI: 10.1084/jem.20031560. View

Solomon S, Aubrey M, Zhang X, Jackson K, Morris L, Holland H . Class II HLA mismatch improves outcomes following haploidentical transplantation with posttransplant cyclophosphamide. Blood Adv. 2020; 4(20):5311-5321. PMC: 7594387. DOI: 10.1182/bloodadvances.2020003110. View

Jia W, Poe J, Su H, Anand S, Matsushima G, Rathmell J . BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation. Blood. 2021; 137(18):2544-2557. PMC: 8109011. DOI: 10.1182/blood.2020008040. View

Miklos D, Kim H, Miller K, Guo L, Zorn E, Lee S . Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood. 2004; 105(7):2973-8. PMC: 1350982. DOI: 10.1182/blood-2004-09-3660. View

Umino K, Morita K, Ikeda T, Kawaguchi S, Nagayama T, Ito S . Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect. Blood. 2023; 142(11):1008-1021. DOI: 10.1182/blood.2023019799. View

Porcheray F, Miklos D, Floyd B, Sarantopoulos S, Bellucci R, Soiffer R . Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation. Transplantation. 2011; 92(3):359-65. PMC: 3263512. DOI: 10.1097/TP.0b013e3182244cc3. View

Nakasone H, Sahaf B, Miklos D . Therapeutic benefits targeting B-cells in chronic graft-versus-host disease. Int J Hematol. 2015; 101(5):438-51. DOI: 10.1007/s12185-015-1782-4. View

Popli R, Sahaf B, Nakasone H, Lee J, Miklos D . Clinical impact of H-Y alloimmunity. Immunol Res. 2014; 58(2-3):249-58. PMC: 4380433. DOI: 10.1007/s12026-014-8514-3. View

10.

Wolff D, Radojcic V, Lafyatis R, Cinar R, Rosenstein R, Cowen E . National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report. Transplant Cell Ther. 2021; 27(10):817-835. PMC: 8478861. DOI: 10.1016/j.jtct.2021.06.001. View